Shojak 5 Mg

World’s No.1 Prescribed JAK Inhibitors

Tofacitinib is the first approved pill of its kind (JAK inhibitor) that treats adults with moderate to severe rheumatoid arthritis, active psoriatic arthritis, and moderate to severe ulcerative colitis.

For adults with moderate to severe ulcerative colitis when 1 or more tumor necrosis factor (TNF) blockers did not work well or cannot be tolerated

For adults with moderate to severe rheumatoid arthritis

• Reduce Symptoms, Including Rectal Bleeding And Stool Frequency, In As Early As 2 Weeks
• Improve The Appearance Of The Intestinal Lining
• Can Provide Lasting SteroidFree Remission
• Janus kinase (JAK) inhibitor that works inside your cells to disrupt pathways believed to play a role in
  nflammation associated with RA.
• Start reducing RA joint pain and swelling in as early as 2 weeks.
• Helps Stop Further Joint Damage and Improved the ability to accomplish certain daily activities

To Normalise the Irregularity and Complications of Menstrual Cycle